BOSTON SCIENTIFIC CORP — Director's Dealing 2025

Feb 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2025-02-12

Reporting Person: O'Sullivan Miriam (SVP, Chief HR Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-12	Common Stock	M	961.0000	$0.0000	Acquired	12917.0000	Direct
2025-02-12	Common Stock	F	338.0000	$105.7700	Disposed	12579.0000	Direct
2025-02-12	Common Stock	M	65.0000	$0.0000	Acquired	1567.0000	Indirect
2025-02-12	Common Stock	F	23.0000	$105.7700	Disposed	1544.0000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-12	Restricted Stock Units	$	M	961.0000	Disposed	2028-02-12	Common Stock (961.0000)	Direct
2025-02-12	Restricted Stock Units	$	M	65.0000	Disposed	2028-02-12	Common Stock (65.0000)	Indirect

Footnotes

F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.

F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.